DUSTIN TIMMONS: Open Payments
NPI 1912164229 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 19 payments from 6 companies in 2025. Trend: 2023 $240 · 2024 $587 · 2025 $466
Food & beverage: $354Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $190 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Alkermes, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $17 |
Products named: INGREZZA, Qelbree, REXULTI, ARISTADA, Dyanavel XR.
Industry payments across AR — which companies pay providers there.
